Side effects like nausea or fatigue are common, especially in the early weeks of treatment, and they tend to be tied closely to when the medication peaks in your system
Texada MJ, Malita A, Rewitz K
Haghikia A, Li XS, Liman TG, et al
Metabolic Health Clinical Implications: While human trials are limited, they demonstrate significant metabolic improvements particularly with respect to insulin resistance and glucose control
By developing this in-depth understanding of the impacts of the GLP-1s on patient populations, treatment paradigms and clinician messaging, MedTech companies will be able to make informed strategic decisions to stay the course or pivot to other promising segments if needed